Stocks-MCRB-Seres Therapeutics Inc

MCRB Seres Therapeutics Inc

5.47 0.01 (0.18%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Stocks-MCRB-Seres Therapeutics Inc
MCRB Seres Therapeutics Inc
Invest
3.60% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
681.52M
Dayโ€™s Range
5.44
-
5.57
52W Range
2.50
-
9.46
Volume (3M)
760.35K
Price-Earnings Ratio
-
Revenue
13.37M

Seres Therapeutics Inc Latest News

View All
Seres Therapeutics Inc. (MCRB) can excel with these strategiesSeres Therapeutics Inc. (MCRB) can excel with these strategiesUS Post News12 days agoSeres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces SER-155 Phase 1b Study ProgressSeres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces SER-155 Phase 1b Study ProgressBioSpace28 days agoSeres Therapeutics to Present at 41st Annual J.P. Morgan Healthcare ConferenceSeres Therapeutics to Present at 41st Annual J.P. Morgan Healthcare ConferenceBioSpace29 days ago
Pinned Post
eToro Team
eToro
8 days ago
๐ŸŽ‰ Hereโ€™s a little preview introducing 16 YEARS of INVESTING on eToro ๐Ÿ˜๐Ÿค‘ With love, - The eToro Team youtu.be/UFYvpJxh2qA
How can eToro celebrate 16 years of Investing?
youtu.be
Celebrating 16 years of investing together ๐Ÿ’š #etoro16
Like CommentShare
Show more comments2 of 51
1 reply
null
.
Top Discussions
MarketUpdates
United Kingdom
2 months ago
Edited
$MCRB (Seres Therapeutics Inc) Q4 2022 earnings report is expected to be released
28
FEB
REPORTS
Seres Therapeutics Inc Q4 2022 earnings report is expected to be released before market open
Notify me
MCRB
MCRB
Seres Therapeutics Inc
5.47
0.01
(0.18%)
Trade
MCRB
Seres Therapeutics Inc
5.46
0.01 (0.18%)
Trade
Like CommentShare
MarketUpdates
United Kingdom
2 months ago
$MCRB (Seres Therapeutics Inc) Q4 2022 earnings report is expected to be released
Like CommentShare
RonnyHerroelen
Belgium
3 months ago
$MCRB (Seres Therapeutics Inc) go up today
MCRB
Seres Therapeutics Inc
5.46
0.01 (0.18%)
Trade
Like CommentShare
Christian Rauchenwald
Germany
3 months ago
๐Ÿš€ Friday's ๐˜๐—ผ๐—ฝ ๐—ด๐—ฎ๐—ถ๐—ป๐—ฒ๐—ฟ๐˜€ $EGHT (8x8 Inc) $MCRB (Seres Therapeutics Inc) $DXCM (DexCom Inc) $PFSI (PennyMac Financial Services Inc.) $KNSL (Kinsale Capital Group Inc.) ๐Ÿ”ด NASDAQ YTD-Performance: -๐Ÿฎ๐Ÿต.๐Ÿด๐Ÿด% ๐ŸŸข My YTD-Performance: +๐Ÿฐ๐Ÿฎ.๐Ÿญ๐Ÿญ% ๐ŸŸข 2021 +๐Ÿฏ๐Ÿฐ.๐Ÿณ๐Ÿด% ๐ŸŸข 2020 +๐Ÿฎ๐Ÿต.๐Ÿด๐Ÿฌ% ๐Ÿ“Œ... Show More
Like CommentShare
MarketUpdates
United Kingdom
3 months ago
Edited
$MCRB (Seres Therapeutics Inc) Q3 2022 earnings report is expected to be released
2
NOV
REPORTS
Seres Therapeutics Inc Q3 2022 earnings report released before market open
MCRB
MCRB
Seres Therapeutics Inc
5.47
0.01
(0.18%)
Trade
MCRB
Seres Therapeutics Inc
5.46
0.01 (0.18%)
Trade
Like CommentShare

About Seres Therapeutics Inc

Operating internationally, the healthcare firm Seres Therapeutics works to develop biological drugs. The company seeks to revolutionise the treatment for a range of diseases through human microbiome modulation. Founded in 2010, Seres Therapeutics has headquarters in Cambridge, Massachusetts. Listed under the MCRB ticker, the company's stock is available on the NASDAQ GS stock market. Find the best time to buy MCRB stock by following it with your eToro watchlist.
333
Employees
Cambridge, Massachusetts, US
HQ
2010
Founded
Eric D. Shaff, MBA
CEO
Show More
Med TechNASDAQ

Upcoming Earnings

28
FEB
REPORTS
Seres Therapeutics Inc Q4 2022 earnings report is expected to be released before market open

ESG: A New Source of Insight

What is an ESG Score?
This number is a measure of a companyโ€™s exposure to environmental, social, and governance risks. Influencing factors include energy efficiency, safety, social policies, and more. Learn More
Powered by ESG Book
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
46
Low
Industry 
Avg. 45 
32
Environment
41
Social
55
Governance

People Also Bought